Ann: Symbion to distribute Bod portfolio of natural medicines, page-3

What a surprise to wake to another major wholesale distribution deal with Symbion.

In two weeks BDA management have finalised two major distribution deals with API and Symbion and expanded exponentially their sales potential. Hopefully this is reflected in the quarter updates in June 2018.

What I like BDA to now to do is to grow partnerships with global cannabis companies with IP similarly to Linea and import their cannabis active compounds for product development.